Which longevity peptides have human evidence? GHK-Cu, MOTS-c, sermorelin
No peptide has been shown to extend human lifespan. The peptides with the strongest human evidence are FDA-approved drugs such as semaglutide, which lowered the combined risk of heart attack, stroke and cardiovascular death in the SELECT trial published in the New England Journal of Medicine in 2023. Popular longevity peptides such as GHK-Cu, MOTS-c and sermorelin have small human studies, lab-marker data or mostly animal research behind them, which means they can be reasonable tools under physician supervision but should never be sold to you as proven anti-aging drugs.
That gap between promise and proof is the whole story. UCLA Health summed it up in a headline: with peptide supplements, marketing outpaces medicine. Cedars-Sinai frames peptides and aging around potential, and that is the right word. Potential is not proof. Below is the candid, peptide-by-peptide grading most clinic pages leave out.
How we graded the evidence
We sorted each peptide by the best evidence that exists for it in people, not by how often it shows up in ads.
| Grade | What it means | What it can tell you |
|---|---|---|
| A: Human outcome trials | Large randomized controlled trials measuring real outcomes such as heart attacks, strokes or death | The drug changes what actually happens to people |
| B: Small human studies | Small trials or studies measuring surrogate markers such as hormone levels, skin measurements or blood NAD+ | The compound does something measurable in people, but not that it improves long-term health |
| C: Animal or lab only | Cell culture, mouse or other animal studies, plus mechanism research | A plausible idea worth testing, nothing more |
Here is how the most marketed longevity peptides land.
| Peptide | Marketed for | Best human evidence | Grade for longevity claims | FDA status for aging |
|---|---|---|---|---|
| Semaglutide, tirzepatide (GLP-1 class) | Weight, metabolic health | Large randomized trials; SELECT cardiovascular outcomes for semaglutide | A for specific outcomes | Branded products approved for specific indications; not approved as anti-aging drugs |
| Sermorelin, ipamorelin, CJC-1295 | Growth hormone, body composition, sleep, recovery | Small studies showing growth hormone and IGF-1 rise | B for lab effects; no lifespan data | Not approved for aging |
| GHK-Cu | Skin, hair, tissue repair | Topical skin studies | B for topical skin; C for injectable claims | Not approved for aging |
| MOTS-c | Metabolism, mitochondrial function | Mostly animal and cell research | C | Not approved |
| Epitalon | Telomeres, longevity | Mostly lab and animal work | C | Not approved |
| Thymosin alpha-1 | Immune support | Human studies in specific diseases | No longevity data | Not approved for aging |
| NAD+ precursors (not peptides) | Energy, cellular aging | Small trials showing blood NAD+ rises | B for levels; benefit unclear | Not approved for aging |
GHK-Cu: real skin data, thin injectable data
GHK-Cu is a small copper-binding peptide that occurs naturally in the body. Most of the human research on it comes from topical skin care: creams and serums evaluated for skin appearance, firmness and wrinkles. Those studies tend to be small and short, but they are human data, and they support GHK-Cu as a reasonable cosmetic ingredient.
The injectable claims are a different matter. Statements that injected GHK-Cu resets gene expression, rejuvenates organs or slows whole-body aging rest largely on lab and animal work. We are not aware of controlled human trials showing that injectable GHK-Cu improves healthspan or lifespan.
BioCure's peptide program includes GHK-Cu, including a "Glow" stack that pairs it with BPC-157 and TB-500. If you choose a protocol like that, you should know that the human evidence for BPC-157 and TB-500 is also limited. The honest framing is a trial with a defined goal, such as skin quality or recovery, tracked over time, not a longevity guarantee.
MOTS-c: a fascinating mechanism, mostly animal data
MOTS-c is a mitochondrial-derived peptide, meaning it is encoded in mitochondrial DNA rather than the nucleus. That discovery is genuinely interesting, and in animal studies MOTS-c has shown effects on metabolism, insulin sensitivity and exercise capacity.
In humans, most published work measures how much MOTS-c people naturally carry, for example comparing levels across ages or health conditions. That is observational data. It does not show that injecting MOTS-c changes how you age. Controlled human trials testing MOTS-c for aging outcomes are lacking, which puts it at Grade C for longevity claims. We cover the science in more depth in our MOTS-c explainer.
Sermorelin, ipamorelin and CJC-1295: hormone effects, no lifespan proof
These are growth hormone secretagogues. Sermorelin and CJC-1295 mimic growth hormone releasing hormone, and ipamorelin acts on the ghrelin receptor. All three prompt your pituitary to release more of your own growth hormone, which in turn raises IGF-1.
That hormonal effect is real and measurable in people, which is why we grade the lab effect at B. What has not been shown is that raising growth hormone or IGF-1 this way helps you live longer. There is even a reason for caution: in animal research, lower growth hormone and IGF-1 signaling is often linked with longer lifespan. Pushing IGF-1 higher is not automatically pro-longevity. Goals like sleep quality, body composition or recovery are more realistic, and IGF-1 should be checked so it stays in a sensible range.
None of these peptides is FDA approved for aging. The rules on which peptides compounding pharmacies may use have been changing, so a responsible clinic confirms that a peptide can be lawfully compounded before prescribing it and works only with licensed compounding pharmacy partners. For a side-by-side look, read sermorelin vs ipamorelin after 40.
Epitalon, thymosin alpha-1 and NAD+: what is claimed vs what is shown
- Epitalon. Claimed to activate telomerase and lengthen telomeres. The supporting research is mostly cell and animal work from a small number of research groups, without large independent human trials. Grade C.
- Thymosin alpha-1. Studied in humans as an immune modulator in specific diseases. That is real clinical research, but it is not longevity research, and it does not show that healthy people age more slowly on it.
- NAD+ precursors. Not peptides, but often sold alongside them. Small human trials show that precursors such as NR and NMN can raise NAD+ levels in the blood. Whether that translates into better health or slower aging has not been consistently shown.
The pattern is the same each time: a believable mechanism, encouraging early data, and a long distance still to travel before anyone can claim a longevity benefit.
Where FDA-approved peptides actually fit
If you want a peptide with outcome-level human evidence, look at the GLP-1 class. Semaglutide and tirzepatide are peptide drugs, and they have been tested in large randomized trials.
The SELECT trial, published in the New England Journal of Medicine in 2023, enrolled about 17,600 adults with overweight or obesity and established cardiovascular disease who did not have diabetes. Semaglutide lowered the relative risk of major adverse cardiovascular events (cardiovascular death, nonfatal heart attack or nonfatal stroke) by 20 percent compared with placebo. That is Grade A evidence for a specific group of people. It is not proof that GLP-1s slow aging in healthy adults.
Two cautions apply. First, compounded versions are not FDA approved, and the SELECT results come from the branded product studied in the trial. Second, GLP-1s have real side effects, gastrointestinal symptoms are common, and lean muscle needs protecting during weight loss. BioCure's medical weight loss program uses semaglutide or tirzepatide only after a consultation and blood panel, with physician check-ins and maintenance support after you reach your goal.
How a clinician should measure whether anything is working
Given the evidence above, the most important part of peptide therapy for longevity is measurement. Without it, you are paying for a hope.
| Goal | What to measure | When |
|---|---|---|
| Growth hormone peptides | IGF-1, fasting glucose, sleep and recovery notes | Baseline, then periodically during treatment |
| Body composition | Weight, waist, lean mass vs fat mass | Baseline and at regular check-ins |
| Metabolic health | Lipids, glucose markers, blood pressure | Baseline and follow-up panels |
| Skin or recovery peptides | Photos, symptom and function scores | Baseline and at the end of a defined trial |
| Biological age (optional) | Epigenetic test such as TrueAge | Baseline and repeat, read with caution |
Epigenetic clocks are interesting, but they are not validated as proof that a treatment extends life. Treat them as one data point, not a scorecard. A good plan sets a goal, a time frame and a rule: if nothing measurable changes, stop.
How to choose a peptide therapy clinic
Whether you are searching for peptide therapy longevity clinics in New York City, Florida or anywhere in the United States, use the same criteria:
- A physician evaluates you and orders labs before prescribing.
- The clinic tells you which claims are animal-only.
- Prescriptions go through licensed compounding pharmacy partners.
- Follow-up labs are part of the plan, not an upsell.
- Pricing is explained up front, including whether labs and consults are included.
Here is where BioCure fits. We are a physician-led telehealth clinic based in the Fort Lauderdale area, licensed in 47 states, with availability confirmed at intake. Our peptide page describes 15+ protocols, including GHK-Cu, MOTS-c and sermorelin, and your physician picks a protocol from your labs and goals. The video consultation is $199 and can be credited back with a membership. Diagnostics include a 90+ biomarker panel with results in 7 to 14 days, and every result is interpreted with a specialist. Medications ship to your door, typically 5 to 10 business days after your consultation and testing. We do not bill insurance directly, though many patients use HSA or FSA funds with the documentation we provide. If you need insurance billing or want an in-person clinic in your own city, a local practice may suit you better.
Frequently asked questions
Do peptides actually slow aging?
No peptide has been proven to slow human aging or extend lifespan. Some have small human studies showing measurable effects, such as higher IGF-1 or better skin measurements, and many longevity claims rest on animal data. The best outcome evidence belongs to FDA-approved GLP-1 drugs for specific conditions.
Which peptide has the most evidence for longevity?
Semaglutide has the strongest outcome data, because the SELECT trial showed a 20 percent relative reduction in major cardiovascular events in adults with obesity and heart disease. That supports a specific use, not a general anti-aging claim. Among classic longevity peptides, none has outcome-level human data.
Is GHK-Cu worth injecting?
The solid human data for GHK-Cu comes from topical skin products. Injectable claims for whole-body rejuvenation rest mostly on lab and animal research. If you try it, do so with a physician, a defined goal and a plan to reassess.
Are compounded peptides safe and legal in 2026?
Compounded peptides are not FDA approved, and the rules on which peptides pharmacies may compound have been changing. Safety depends on the specific peptide, the pharmacy and medical supervision. Use a clinic that prescribes through licensed compounding pharmacy partners and monitors you with labs.
What should I look for in a peptide therapy longevity clinic?
Look for a physician evaluation, baseline and follow-up labs, honest explanations of the evidence and clear pricing. Avoid clinics that promise specific results or sell peptides without testing. BioCure is physician-led, treats patients in 47 states and builds each protocol from your labs.
The bottom line
Peptides are not magic, and they are not useless. Used honestly, with clear goals and real measurement, some can support how you feel and function. Longevity is not accidental, it is intentional, and intention starts with knowing what the evidence actually says.
Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838. Your future self will thank you.